The mTOR pathway, downstream of PI3K/AKT, directs serine-threonine protein kinase, thereby modulating tumor cell proliferation, invasion, and metastasis via ribosomal protein kinase activation (Fig. 5B). This evidence concerns the gene MTOR and neoplasm.